The FITC-conjugated EpCAM antibody (green), PE-conjugated CD44 antibody (red), PE-conjugated CD24 antibody (red), and PE-conjugated CD133 antibody (red) were used to characterize the pancreatic cancer stem cells. This evidence concerns the gene PROM1 and pancreatic neoplasm.